Sort by
Refine Your Search
-
dedicated professional services teams. About the role We are looking for a Programme Officer to join our Professional Services team in the Arts Cluster to support the Digital Humanities and Culture, Media and
-
for students, staff & partner providers, enabling the delivery of education through managing quality, programme, placement and assessment administration. We provide dedicated student support that prioritises
-
line with King’s Education Strategy. Its portfolio includes flagship undergraduate and pre-university summer schools, customised undergraduate and postgraduate student programming for international
-
support processes within our main workstreams of Assessment and Award, Programme Planning and Delivery and Student Communications and Knowledge ensuring accurate and timely record management across multiple
-
for students, staff & partner providers, enabling the delivery of education through managing quality, programme, placement and assessment administration. We provide dedicated student support that prioritises
-
Job id: 117485. Salary: £34,179 - £37,546 per annum, including London Weighting Allowance. Posted: 16 June 2025. Closing date: 01 July 2025. Business unit: Faculty of Arts & Humanities. Department: Arts & Humanities Cluster Offices. Contact details:Charlotte Taylor / Louise Beach. ...
-
central directorates to provide a high-quality administrative support service and student and staff experience. About the role We are looking to recruit a Senior Programme Officer to support the running
-
, Guy’s, St Thomas’ and Waterloo campuses, our academic programme of teaching, research and clinical practice is embedded across five Departments. About the role The EMBRACE Chief Operating Officer is the
-
teaching. Specifically, you will help to lead the Chemistry PGCE programme and deliver chemistry content and skills to students. The role involves ensuring that the course design and delivery comply with
-
Now–funded programme, a major initiative uniting scientists and clinicians at King’s and the Institute of Cancer Research to develop novel immune therapeutic strategies for hard-to-treat triple negative